Oncuria Bladder Cancer Tests Receive Medicare Coverage Effective January 1, 2024 | Reports DiaCarta

Oncuria Bladder Cancer Tests, developed by Nonagen Bioscience and validated by DiaCarta as a Lab Developed Test (LDT), at its CAP-accredited and CLIA-certified laboratory, have received Medicare coverage effective January 1, 2024.